| Drug Name: | Clofazimine (2030-63-9) |
|---|---|
| PubChem ID: | 2794 |
| SMILES: | CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl |
| InchiKey: | WDQPAMHFFCXSNU-UHFFFAOYSA-N |
| Therapeutic Category: | Analgesics, Anti-Bacterial Agents, Anti-Infective Agents, Anti-Inflammatory Agents, Antirheumatic Agents, Coloring Agents, Leprostatic Agents, Peripheral Nervous System Agents, Sensory System Agents |
| Molecular Weight (dalton) | : | 473.407 |
| LogP | : | 7.4898 |
| Ring Count | : | 3 |
| Hydrogen Bond Acceptor Count | : | 4 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 42.21 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Dapsone (80-08-0) | Reduce The Anti-Inflammatory Effects Of Clofazimine | Antagonistic | Not known | Possible incompatibility of dapsone with clofazimine in the treatment of patients with erythema nodosum leprosum |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category